AKAP3 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84413
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human AKAP3. Peptide sequence: PGSGDRVSGSSQSPPNLKYKSTLKIKESTKERQGPDDKPPSKKSFFYKEV The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for AKAP3 Antibody - BSA Free
Western Blot: AKAP3 Antibody [NBP2-84413]
Western Blot: AKAP3 Antibody [NBP2-84413] - Host: Rabbit. Target Name: AKAP3. Sample Tissue: Human COLO205 Whole Cell. Antibody Dilution: 1.0ug/mlApplications for AKAP3 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: AKAP3
Alternate Names
A kinase (PRKA) anchor protein 3, AKAP110AKAP 110, AKAP-3, A-kinase anchor protein 110 kDa, Cancer/testis antigen 82, CT82A-kinase anchor protein 3, Fibrous sheath protein of 95 kDa, fibrousheathin 1, Fibrousheathin I, Fibrousheathin-1, FSP95A-kinase anchor protein, 110kDa, PRKA3, protein kinase A anchoring protein 3, Protein kinase A-anchoring protein 3, SOB1fibrous sheath protein, 95kDa, Sperm oocyte-binding protein, sperm oocyte-binding protein 1
Gene Symbol
AKAP3
Additional AKAP3 Products
Product Specific Notices for AKAP3 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...